The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Arnason, Barry G.
One or more keywords matched the following items that are connected to Arnason, Barry G.
Item TypeName
Concept Multiple Sclerosis, Relapsing-Remitting
Academic Article Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis.
Academic Article Interferons in relapsing remitting multiple sclerosis.
Academic Article Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
Academic Article Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
Academic Article Interferon ß-1b and glatiramer acetate effects on permanent black hole evolution.
Academic Article Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
Academic Article 250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study.
Academic Article Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial.
Academic Article Tumour Necrosis Factor Neutralization in MS: A Cautionary Tale.
Academic Article Efficacy and safety of interferon beta-1b sc in older RRMS patients--a posthoc analysis of the BEYOND study.
Academic Article Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b: a post hoc analysis of the BEYOND study.
Academic Article Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Academic Article Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.
Search Criteria
  • Multiple Sclerosis Relapsing Remitting